BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20199759)

  • 1. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009.
    Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K
    Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005.
    Phongsamart W; Srifeungfung S; Dejsirilert S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Chokephaibulkit K
    Vaccine; 2007 Jan; 25(7):1275-80. PubMed ID: 17092618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Sricharoenchai S; Chokephaibulkit K
    Hum Vaccin Immunother; 2014; 10(7):1866-73. PubMed ID: 25424794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.
    Ho PL; Chiu SS; Ang I; Lau YL
    Vaccine; 2011 Apr; 29(17):3270-5. PubMed ID: 21352937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
    Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
    Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC; Hulten KG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.
    Paraskakis I; Kafetzis DA; Chrisakis A; Papavasilliou H; Kirikou H; Pangalis A; Tzouvelekis LS; Athanasiou T; Legakis NJ;
    Clin Microbiol Infect; 2006 May; 12(5):490-3. PubMed ID: 16643530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.
    Imöhl M; Reinert RR; van der Linden M
    Clin Microbiol Infect; 2009 Nov; 15(11):1008-12. PubMed ID: 19681946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.